n-methyl-3,4-methylenedioxyamphetamine has been researched along with Central Hypothyroidism in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, AL | 1 |
| Gilman, TL | 1 |
| Banks, ML | 1 |
| Sprague, JE | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Central Hypothyroidism
| Article | Year |
|---|---|
Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Topics: Analysis of Variance; Animals; Body Temperature; Chromatography, High Pressure Liquid; Corpus Striat | 2006 |